SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (2342)4/15/1999 3:11:00 PM
From: Biomaven  Read Replies (1) | Respond to of 10280
 
Bob -

Yes, you are correct that only royalties on the "straight-up" version of Allegra are at risk. The cocktails are all still covered by the agreement, no matter what the outcome of the interference.

Don't know what the mix of sales between the two versions is likely to be, though.

Peter



To: RCMac who wrote (2342)4/15/1999 4:19:00 PM
From: Thomas M.  Read Replies (1) | Respond to of 10280
 
... Rick Harmon's long piece on SEPR ...

Can you please dig this up when you get a chance? It sounds like good reading.

Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News